Rifampicin-induced CYP3A4 activation in CTX patients cannot replace chenodeoxycholic acid treatment

Auryan Szalat, Pavel Gershkovich, Alon Ben-Ari, Aviv Shaish, Yael Liberman, Eti Boutboul, Marc Gotkine, Amnon Hoffman, Dror Harats, Eran Leitersdorf, Vardiella Meiner

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Rifampicin-induced CYP3A4 activation in CTX patients cannot replace chenodeoxycholic acid treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences